Gene therapy may be 'one-shot stop' for rare bone disease
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...
BioSpace23hOpinion
Opinion: Companies Vie to Develop a Hunter Syndrome Therapy That Reaches the Brain
Several companies—including JCR Pharmaceuticals, Denali Therapeutics and Regenxbio— have products in the pipeline that could ...
Hosted on MSN3d
Exposed Part 1: the Human Radiation Experiments at Hunter’s Point from SF Public Press
Today we present the first half of a two-part radio documentary from our friends at SF Public Press, “Exposed,” opening a ...
Le Lézard6d
JCR Pharmaceuticals to Present at the 21st Annual WORLDSymposiumtm 2025
JCR Pharmaceuticals Co., Ltd. (TSE 4552; "JCR") announced today that it will present at the 21st Annual WORLDSymposiumtm 2025, held February 3-7, 2025, in San Diego, Calif. The poster presentations ...